Recommendations for the diagnosis and management of Niemann–Pick disease type C: An updateMarc C. Patterson, Frits A. Wijburg, Marie T. Vanier et al.|Molecular Genetics and Metabolism|2012Cited by 478
Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus documentMarieke Biegstraaten, Carla E. M. Hollak, Derralynn Hughes et al.|Orphanet Journal of Rare Diseases|2015Cited by 345
Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo‐controlled studyChristian J. Hendriksz, Wolfgang Dummer, Barbara K. Burton et al.|Journal of Inherited Metabolic Disease|2014Cited by 211
Recommendations for the management of MPS IVA: systematic evidence- and consensus-based guidanceMehmet Umut Akyol, Maurizio Scarpa, Tord D. Alden et al.|Orphanet Journal of Rare Diseases|2019Cited by 114
Mechanisms of Mitochondrial Dysfunction in Lysosomal Storage Disorders: A ReviewKarolina M. Stępień, Iain P. Hargreaves, Federico Roncaroli et al.|Journal of Clinical Medicine|2020Cited by 101